Eliminating stroke as a leading cause of death and disability by increasing 20x the rate of stroke treatment within the golden hour in 10 years.
Location: New Zealand
Employees: 1-10
Total raised: $7.28M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 19.07.2023 | New Zealan... | nzgcp.co.n... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.02.2026 | Seed | $7.28M | Nuance Con... |
Mentions in press and media 3
| Date | Title | Description |
| 11.02.2026 | Wellumio Raises $7.28M to Bring MRI Scans Directly to the Bedside | (L to R) Dion Thomas, Dr Shieak Tzeng, Dr Sergei Obruchkov, and Dr Paul Teal What You Should Know The Raise: New Zealand-based Wellumio has raised $7.28M in the first close of its pre-Series A round, led by Nuance Connected Capital, to fast... |
| 06.02.2025 | Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study) | "Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical 'golden hour." A Me... |
| 06.01.2025 | Wellumio Expands Stroke Detection Device to U.S. Market | What You Should Know: – Wellumio, a New Zealand-based medical device innovator announced the launch of a new subsidiary in California, a strategic move aimed at facilitating US-based clinical trials for its groundbreaking Axana device and a... |